Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prevalence and clinical characteristics of unremembered nocturnal eating in diabetic subjects: Kurume sleep trouble in obesity and metabolic disorders (KUSTOMED) study.
Yamada K, Nakayama H, Kato T, Tajiri Y, Sato S, Hirao S, Oshige T, Hara K, Iwata S, Kato N, Sasaki Y, Hasuo R, Yoshinobu S, Mitsuzaki K, Kato T, Hashinaga T, Muraishi K, Ohki T, Kaku H. Yamada K, et al. Among authors: oshige t. Endocr J. 2013;60(9):1059-63. doi: 10.1507/endocrj.ej13-0098. Epub 2013 Jun 14. Endocr J. 2013. PMID: 23774071 Free article.
Adding of Sitagliptin on Insulin Therapy Effectively and Safely Reduces a Hemoglobin A1c Level and Glucose Fluctuation in Japanese Patients with Type 2 Diabetes.
Tajiri Y, Kawano S, Hirao S, Oshige T, Iwata S, Ono Y, Inada C, Akashi T, Hayashi H, Sato Y, Tojikubo M, Yamada K. Tajiri Y, et al. Among authors: oshige t. Int Sch Res Notices. 2014 Aug 3;2014:639489. doi: 10.1155/2014/639489. eCollection 2014. Int Sch Res Notices. 2014. PMID: 27419209 Free PMC article.
Long-term safety and efficacy of alogliptin, a DPP-4 inhibitor, in patients with type 2 diabetes: a 3-year prospective, controlled, observational study (J-BRAND Registry).
Ueki K, Tanizawa Y, Nakamura J, Yamada Y, Inagaki N, Watada H, Shimomura I, Nishimura R, Miyoshi H, Abiko A, Katagiri H, Hayashi M, Shimada A, Naruse K, Fujimoto S, Fujiwara M, Shikata K, Okada Y, Araki E, Yamazaki T, Kadowaki T; J-BRAND Registry Group. Ueki K, et al. BMJ Open Diabetes Res Care. 2021 Jan;9(1):e001787. doi: 10.1136/bmjdrc-2020-001787. BMJ Open Diabetes Res Care. 2021. PMID: 33441417 Free PMC article.
Anagliptin, A Dipeptidyl Peptidase-4 Inhibitor Ameliorates Arterial Stiffness in Association with Reduction of Remnant-Like Particle Cholesterol and Alanine Transaminase Levels in Type 2 Diabetic Patients.
Tahara N, Yamagishi SI, Bekki M, Kodama N, Nakamura T, Sugiyama Y, Oshige T, Kumashiro Y, Honda A, Tahara A, Igata S, Fukumoto Y. Tahara N, et al. Among authors: oshige t. Curr Vasc Pharmacol. 2016;14(6):552-562. doi: 10.2174/1570161114666160625090212. Curr Vasc Pharmacol. 2016. PMID: 27357182 Clinical Trial.
Effects of saturated fatty acids on prostaglandin E 9-keto-reductase.
Oshige T, Ohtsuka T, Mibe M, Nagai K, Yamaguchi M, Ikenoue T, Mori N. Oshige T, et al. Prostaglandins Leukot Essent Fatty Acids. 1992 Mar;45(3):245-7. doi: 10.1016/0952-3278(92)90121-x. Prostaglandins Leukot Essent Fatty Acids. 1992. PMID: 1589452
40 results